Search

everythinglearnresearchcommunity

for

Search:↓

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Coloring shampoos for gray hair may cause gene mutation, reproductive issues, and skin damage, needing stricter regulation and expert consultation.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Water extract of Cacumen Platycladi helps hair growth by activating specific cell pathways.

Parathyroid hormone-related protein helps control hair growth phases in mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Certain natural compounds called terpenes may help prevent prostate cancer.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Eating dairy and high glycemic foods may increase the risk of acne.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Treatments for hair loss vary, but cell-based options may be the future.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Doctors need to be better prepared to assess and treat obesity in patients.

Prolactin may affect hair growth differently based on gender and scalp area.